Clinical Trials on Liver Cirrhosis, Alcoholic

Total 15690 results

Fast Forward Pharmaceuticals

Unknown

Pilot Study of FFP104 Dose Escalation in PBC Subjects

Primary Biliary Cirrhosis

Netherlands, United Kingdom
Instituto Nacional de Ciencias Medicas y Nutricion...

Completed

High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

Mexico
Light Chain Bioscience - Novimmune SA

Terminated

Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody (PIANO)

Primary Biliary Cirrhosis

Italy, United Kingdom
Mayo Clinic
UCB Pharma

Completed

Moexipril for Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis

Liver Cirrhosis, Biliary

United States, Puerto Rico
Virginia Commonwealth University
Oridion

Completed

Development of a Breath Test for Monitoring Patients With Liver Disease

Fatty Liver | Cirrhosis

United States
Chinese University of Hong Kong

Not yet recruiting

Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment

Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)

Hong Kong
RenJi Hospital

Not yet recruiting

SALT for Patients With Hepatic Cirrhosis

Liver Cirrhosis | Liver
Zhujiang Hospital
The Third Affiliated Hospital of Southern Medical University; Shenzhen Hospital... and other collaborators

Enrolling by invitation

Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRI

Cirrhosis | Liver Fibrosis

China
University of Leeds
The Leeds Teaching Hospitals NHS Trust

Unknown

Functional MRI to Determine Severity of Cirrhosis

Liver Cirrhosis | Liver Fibrosis

United Kingdom
Baermed

Unknown

Hepatocyte Matrix Implant Study (HMI)

Liver Cirrhosis | Liver Disease

Switzerland
Haisco Pharmaceutical Group Co., Ltd.

Recruiting

To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .

Non-Alcoholic Steatohepatitis (NASH)

China
AstraZeneca

Active, not recruiting

A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects

Non-alcoholic Steatohepatitis (NASH)

United States
Zhejiang Medicine Co., Ltd.
The Affiliated Hospital of Hangzhou Normal University; R&G Pharma Studies Co...

Completed

Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic Steatohepatitis

NASH (Non-Alcoholic Steatohepatitis)

China
Regeneron Pharmaceuticals

Terminated

Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)

Non-alcoholic Steatohepatitis (NASH)

Brazil, United States, Puerto Rico, Korea, Republic of, Mexico
NorthSea Therapeutics B.V.

Active, not recruiting

A Phase 2b Study of Icosabutate in Fatty Liver Disease (ICONA)

Non Alcoholic Steatohepatitis (NASH)

United States, Puerto Rico
Hepanova Inc.

Unknown

A Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects

Non-Alcoholic Steatohepatitis (NASH)

United States
University of Palermo

Unknown

Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis

•Non-alcoholic Steatohepatitis (NASH)

Italy
University of Colorado, Denver

Completed

The Effect of Protandim on Non-alcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis

United States
Pfizer

Completed

Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH

Non-Alcoholic Steatohepatitis(NASH)

United States
Sohag University

Completed

Acute-On-Chronic Liver Failure In Cirrhotic Patients

Cirrhosis, Liver

Egypt
Postgraduate Institute of Medical Education and...

Completed

Global Coagulation Assessment in Cirrhosis and ACLF

Acute-On-Chronic Liver Failure | Cirrhosis, Liver

India
National Institute of Diabetes and Digestive and...

Completed

Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E

Fatty Liver

United States
Nanfang Hospital of Southern Medical University
LanZhou University; Zhongda Hospital; Ankara University; Xingtai People's Hospital and other collaborators

Recruiting

Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901)

Compensated Cirrhosis

China, Turkey, Thailand
Maja Thiele
University of Oslo; Novo Nordisk A/S; University of Copenhagen; University of Southern... and other collaborators

Recruiting

Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers (SIPHON)

Fibrosis | Liver Diseases, Alcoholic

Denmark
Johns Hopkins University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

INIA Stress and Chronic Alcohol Interactions: Glucocorticoid Antagonists in Heavy Drinkers

Alcohol Use Disorder

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers

Alcohol Drinking | Alcoholism | fMRI

United States
Hospital Sao Rafael
Ministry of Health, Brazil; Ministry of Science and Technology, Brazil

Unknown

Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases

Hepatic Cirrhosis | Chronic Hepatitis

Brazil
Mayo Clinic
American College of Gastroenterology

Completed

Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC) (PBC)

Fatigue | Primary Biliary Cirrhosis

United States
University of Alberta
GlaxoSmithKline; Axcan Pharma

Completed

Study of Combivir for Patients With Primary Biliary Cirrhosis

Primary Biliary Cirrhosis

United States, Canada, United Kingdom
First Affiliated Hospital of Zhejiang University

Completed

Synbiotics Interventions for Managing Cirrhosis and Its Complications

Cirrhosis, Liver | Metagonimiasis

China
Mayo Clinic
Ria Health

Recruiting

Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC) (DALC)

Liver Diseases | Alcohol Use Disorder

United States
University of Malaya

Completed

Short Term Feeding for Asian Patients With Liver Cirrhosis

CIRRHOSIS

Malaysia
Virginia Commonwealth University
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Immuron Ltd.

Completed

Safety and Efficacy of IMM 124-E for Patients With Severe Alcoholic Hepatitis (TREAT)

Hepatitis, Alcoholic

United States
University Hospital Birmingham

Unknown

Alcohol Diet and Drug Use Preceding Alcoholic Hepatitis (ADDUP)

Hepatitis, Alcoholic

United Kingdom
Tianjin Third Central Hospital

Recruiting

Diagnostic Efficacies of Sonazoid-CEUS and EOB-MRI in Patients With High Risk of HCC

Diagnoses Disease | Hepatocellular Cancer | Liver Cirrhoses

China
Tianjin Third Central Hospital

Completed

Comparing the Diagnostic Efficiencies of CEUS and EOB-MRI in Patients With High Risk of HCC

Diagnoses Disease | Hepatocellular Cancer | Liver Cirrhoses

China
University of Medicine and Pharmacy Craiova
University of Medicine and Pharmacy "Victor Babes" Timisoara

Unknown

The Role of Strain Elastography in Staging Liver Fibrosis (SELF)

Cirrhosis | Chronic Liver Disease

Romania
Mirum Pharmaceuticals, Inc.

Completed

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis (CLARITY)

Primary Biliary Cirrhosis | PBC

United States, United Kingdom, Canada
Eccogene

Recruiting

FTIH of ECC4703 in Healthy Volunteers

Non-alcoholic Steatohepatitis (NASH)

United States
Guangdong Raynovent Biotech Co., Ltd

Completed

Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis (NASH)

China
Novartis Pharmaceuticals

Terminated

Safety, Tolerability, Pharmacokinetics and Efficacy of LMB763 in Patients With NASH

Non-alcoholic Steatohepatitis NASH

United Kingdom, United States, Australia, New Zealand, Switzerland, Jordan, Georgia, Puerto Rico
Hoffmann-La Roche

Completed

Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis (NASH)

France
University of Zurich

Completed

Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D

Non-alcoholic Steatohepatitis (NASH)

Switzerland
Milton S. Hershey Medical Center

Withdrawn

NASH-FITTER: Nonalcoholic Steatohepatitis Fitness Intervention Treatment Targeting Endothelial Dysfunction Reversal (NASH-FITTER)

NASH - Nonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver Disease | Non Alcoholic Steatohepatitis
Taichung Veterans General Hospital

Unknown

Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities

Liver Cirrhosis | Liver Cancer

Taiwan
Virginia Commonwealth University
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis (CITRIS-AH)

Sepsis | Alcoholic Hepatitis

United States
Ain Shams University

Completed

Omega 3 Supplementation in Children With Non Alcoholic Fatty Liver (omega 3)

Fatty Liver

Egypt
Assistance Publique - Hôpitaux de Paris

Terminated

Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure (NORFLOCIR)

Cirrhosis

France
Assistance Publique - Hôpitaux de Paris

Completed

Clinical Trial of Pentoxifylline in Patient With Cirrhosis (PENTOCIR)

Liver Failure | Cirrhosis

France

Clinical Trials on Liver Cirrhosis, Alcoholic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Croatia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations